These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22322241)

  • 1. PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients.
    Lachance K; Barhdadi A; Mongrain I; Normand V; Zakrzewski M; Leblanc MH; Racine N; Carrier M; Ducharme A; Turgeon J; Dubé MP; Phillips MS; White M; de Denus S
    Pharmacogenet Genomics; 2012 May; 22(5):336-43. PubMed ID: 22322241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between single nucleotide polymorphisms and the development of nephrotoxicity after orthotopic heart transplantation.
    Klauke B; Wirth A; Zittermann A; Bohms B; Tenderich G; Körfer R; Milting H
    J Heart Lung Transplant; 2008 Jul; 27(7):741-5. PubMed ID: 18582803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
    Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I; Hsaiky L; Brown K; Abouljoud M
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation.
    van de Wetering J; Weimar CH; Balk AH; Roodnat JI; Holweg CT; Baan CC; van Domburg RT; Weimar W
    Transplantation; 2006 Dec; 82(12):1744-8. PubMed ID: 17198270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
    Kushwaha SS; Khalpey Z; Frantz RP; Rodeheffer RJ; Clavell AL; Daly RC; McGregor CG; Edwards BS
    J Heart Lung Transplant; 2005 Dec; 24(12):2129-36. PubMed ID: 16364861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1-gene polymorphism in the development of kidney disease after liver transplantation.
    Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Bahra M; Neuhaus P; Schmitz V
    Transplantation; 2012 Mar; 93(5):555-60. PubMed ID: 22366990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients.
    Chinnock TJ; Shankel T; Deming D; Cutler D; Sahney S; Fitts J; Chinnock RE
    Pediatr Transplant; 2011 Nov; 15(7):746-9. PubMed ID: 21883751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.
    de Denus S; Zakrzewski M; Barhdadi A; Leblanc MH; Racine N; Bélanger F; Carrier M; Ducharme A; Dubé MP; Turgeon J; White M
    J Heart Lung Transplant; 2011 Mar; 30(3):326-31. PubMed ID: 21094057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients.
    González-Vilchez F; de Prada JA; Castrillo C; Canteli A; Llano MF; Martín-Durán R
    J Heart Lung Transplant; 2011 May; 30(5):552-7. PubMed ID: 21212001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
    Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
    Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms located in TGFB1, AGTR1, and VEGFA genes are associated to chronic renal allograft dysfunction.
    Jiménez-Sousa MA; Fernández-Rodríguez A; Heredia M; Tamayo E; Guzmán-Fulgencio M; Lajo C; López E; Gómez-Herreras JI; Bustamante J; Bermejo-Martín JF; Resino S
    Cytokine; 2012 Jun; 58(3):321-6. PubMed ID: 22433249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.
    Arora S; Gude E; Sigurdardottir V; Mortensen SA; Eiskjær H; Riise G; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Aukrust P; Solbu D; Iversen M; Gullestad L
    J Heart Lung Transplant; 2012 Mar; 31(3):259-65. PubMed ID: 22333403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal-sparing strategies in cardiac transplantation.
    Gustafsson F; Ross HJ
    Curr Opin Organ Transplant; 2009 Oct; 14(5):566-70. PubMed ID: 19542890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients.
    Potter BJ; Giannetti N; Edwardes MD; Cecere R; Cantarovich M
    Clin Transplant; 2007; 21(3):305-8. PubMed ID: 17488377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function--a single-center experience.
    Siekierka-Harreis M; Kuhr N; Willers R; Ivens K; Grabensee B; Mondry A; Loh MC; Rump LC; Blume C
    Clin Transplant; 2009; 23(5):606-15. PubMed ID: 19681973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.